Synthetic biologists are hard at work developing artificial biological molecules as the first step toward developing a mirror cell that would be immune from infection. If they're successful, it could transform the world of medicine. But while the potential of mirror life is great, so too are the risks. There are warnings of a catastrophic impact if the cells can't be controlled. And that's prompted calls for a moratorium on the research.Guests<a href="https://cbs.umn.edu/directory/kate-adamala">Associate Professor Kate Adamala</a> — Synthetic biologist and professor of genetics, University of Minnesota<a href="https://molecularbiosci.utexas.edu/directory/andrew-ellington">Professor Andrew Ellington</a> — Center for Systems and Synthetic Biology, University of Texas at Austin<a href="https://people.cal.msu.edu/dougl239/">Professor Heather Douglas</a> — Department of Philosophy, Michigan State University<a href="https://www.aizentx.com/ ">Ajay Kshatriya</a> — CEO Aizen Therapeutics

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

The potential benefits and risks of developing "mirror life"

Future Tense

AI Chapters

AI Insights

Reviews